Call Us Today! 832-834-3830

Anavota Behavioral Health Pllc
  • facebook
  • instagram
Prioritize Your Health

For individuals that have treatment-resistant/significant depression and have experienced thoughts of self-harm, undergoing Ketamine Therapy is advised.

About Spravato (Esketamine)

Eskretamine is a nasal spray that the FDA approved in March 2019. Since its approval and distribution for public use, it has helped numerous adults treat depression, especially when combined with an oral antidepressant. Spravato addresses treatment-resistant depression and helps manage depression symptoms and alleviate suicide ideation.

While ketamine has been known as s psychedelic drug, when it is used under the supervision of a licensed health professional, it can be perfectly safe and even save the lives of those who are showing signs of suicide ideation.

Payment for This Service

With Eskretamine being renowned for its positive effects in addressing depression symptoms, it has become widely covered by most major insurance providers. If you are interested in learning more about payments we receive for the treatments we offer, including the Esketamine nasal spray, please click on your state at our Locations tab.

Spravato (Esketamine) Treatment

Since ketamine is a psychedelic substance, individuals who use esketamine for their treatment may experience symptoms of feeling groggy or dizzy, intoxicated, or euphoric. Individuals who have just gotten the treatment are not advised to drive a vehicle, so they need to be accompanied by someone who can drive them to and from their treatment.

Find Out More

Contact Us

Arrange a Meeting with Us!
Book online
Female Doctor Treating Patient Suffering With Depression